NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jiwei Zhang, Fen Ma, Zhe Li, Yuan Li, Xun Sun, Mingxu Song, Fan Yang, Enjiang Wu, Xiaohui Wei, Zhengtao Wang, Li Yang
Format: Artículo Open Access
Veröffentlicht: Wiley 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867002602064969728
author Jiwei Zhang
Fen Ma
Zhe Li
Yuan Li
Xun Sun
Mingxu Song
Fan Yang
Enjiang Wu
Xiaohui Wei
Zhengtao Wang
Li Yang
author_facet Jiwei Zhang
Fen Ma
Zhe Li
Yuan Li
Xun Sun
Mingxu Song
Fan Yang
Enjiang Wu
Xiaohui Wei
Zhengtao Wang
Li Yang
Jiwei Zhang
Fen Ma
Zhe Li
Yuan Li
Xun Sun
Mingxu Song
Fan Yang
Enjiang Wu
Xiaohui Wei
Zhengtao Wang
Li Yang
collection Wiley Open Access
contents NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner Jiwei Zhang Fen Ma Zhe Li Yuan Li Xun Sun Mingxu Song Fan Yang Enjiang Wu Xiaohui Wei Zhengtao Wang Li Yang MedComm AbstractThis study systematically analyzed the molecular mechanism and function of nuclear factor kappa B subunit 2 (NFKB2) in colorectal cancer (CRC) to investigate the potential of NFKB2 as a therapeutic target for CRC. Various experimental techniques, including RNA sequencing, proteome chip assays, and small molecule analysis, were used to obtain a deeper understanding of the regulation of NFKB2 in CRC. The results revealed that NFKB2 was upregulated in a significant proportion of patients with advanced hepatic metastasis of CRC. NFKB2 played an important role in promoting tumor growth through CD8+ T‐cell exhaustion. Moreover, NFKB2 directly interacted with signal transducer and activator of transcription 2 (STAT2), leading to increased phosphorylation of STAT2 and the upregulation of programmed death ligand 1 (PD‐L1). Applying a small molecule inhibitor of NFKB2 (Rg5) led to a reduction in PD‐L1 expression and improved response to programmed death‐1 blockade‐based immunotherapy. In conclusion, the facilitated NFKB2‐STAT2/PD‐L1 axis may suppress immune surveillance in CRC and targeting NFKB2 may enhance the efficacy of immunotherapeutic strategies. Our results provide novel insights into the molecular mechanisms underlying the contribution of NFKB2 in CRC immune escape. 10.1002/mco2.521 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/mco2.521
format Artículo Open Access
id wiley_oa_10_1002_mco2_521
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
Jiwei Zhang
Fen Ma
Zhe Li
Yuan Li
Xun Sun
Mingxu Song
Fan Yang
Enjiang Wu
Xiaohui Wei
Zhengtao Wang
Li Yang
MedComm
NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner Jiwei Zhang Fen Ma Zhe Li Yuan Li Xun Sun Mingxu Song Fan Yang Enjiang Wu Xiaohui Wei Zhengtao Wang Li Yang MedComm AbstractThis study systematically analyzed the molecular mechanism and function of nuclear factor kappa B subunit 2 (NFKB2) in colorectal cancer (CRC) to investigate the potential of NFKB2 as a therapeutic target for CRC. Various experimental techniques, including RNA sequencing, proteome chip assays, and small molecule analysis, were used to obtain a deeper understanding of the regulation of NFKB2 in CRC. The results revealed that NFKB2 was upregulated in a significant proportion of patients with advanced hepatic metastasis of CRC. NFKB2 played an important role in promoting tumor growth through CD8+ T‐cell exhaustion. Moreover, NFKB2 directly interacted with signal transducer and activator of transcription 2 (STAT2), leading to increased phosphorylation of STAT2 and the upregulation of programmed death ligand 1 (PD‐L1). Applying a small molecule inhibitor of NFKB2 (Rg5) led to a reduction in PD‐L1 expression and improved response to programmed death‐1 blockade‐based immunotherapy. In conclusion, the facilitated NFKB2‐STAT2/PD‐L1 axis may suppress immune surveillance in CRC and targeting NFKB2 may enhance the efficacy of immunotherapeutic strategies. Our results provide novel insights into the molecular mechanisms underlying the contribution of NFKB2 in CRC immune escape. 10.1002/mco2.521 http://creativecommons.org/licenses/by/4.0/
title NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
topic MedComm
url https://onlinelibrary.wiley.com/doi/10.1002/mco2.521